Integer Stock Forecast
NYSE: ITGRHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 126.57 -0.02%
ITGR analyst consensus
Consensus (9 analysts)
none
Avg. price target
$121.80-3.78%
- Strong buy 0
- Buy 0
- Hold 9
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 9 Wall Street analysts covering Integer (2026-10-07), 0 rate the stock a buy or strong buy, 9 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $121.80, with a high estimate of $127.00 and a low estimate of $101.00. The average target implies downside of 3.8% from the current price of $126.59.
The spread between the highest and lowest targets is 25.7%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ITGR.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 0 | 0% |
| Hold | 9 | 100% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $101.00 | -20.21% |
| Average target | $121.80 | -3.78% |
| High target | $127.00 | +0.32% |